– USA, IL – AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing, and active material science solutions and services, today announced the election of Board member Candace Matthews as the independent Chair of its Board of Directors, effective at 2023 AGM on May 3, 2023, to succeed George Fotiades, who will remain on the Board of Directors.
About Candace Matthews
Candace Matthews joined the Aptar Board of Directors in May of 2021. She is a highly accomplished business leader with over 35 years of global experience in the healthcare, cosmetics, food, and beverage industries with companies such as Amway, L’Oréal, The Coca-Cola Company, Novartis (CIBA Vision Corporation), as well as Bausch + Lomb, Procter & Gamble, and General Mills.
Candace Matthews also serves on the Board of Directors for MillerKnoll and Société BIC S.A. and was previously a director for Popeyes Louisiana Kitchen.
About Aptar
Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care, and home care. Using insights, proprietary design, engineering, and science to create dispensing, dosing, and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health, and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois, and has 13,500 dedicated employees in 20 countries.
Source: https://www.aptar.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.